The well-studied compound JQ1 functions as a BET inhibitor and has been tested directly in PDA xenograft models with activity partly related to its ability to control cell cycle progression through the CDC25B phosphatase [96]. The gene discussed is DNER; the disease is Patent ductus arteriosus.